Patents Assigned to 4MVac LLC
  • USE OF VIRAL VECTORS FOR CORONAVIRUS VACCINE PRODUCTION
    Publication number: 20230142780
    Abstract: Provided herein are compositions that includes AAVs and AAV vectors that include a sequence encoding a SARS-CoV-2 polypeptide or a fragment thereof. Also provided herein are methods and materials for making and using AAVs and AAV vectors to generate immunity to a coronavirus in a subject.
    Type: Application
    Filed: April 9, 2021
    Publication date: May 11, 2023
    Applicants: 4MVac LLC, Trustees of the University of Pennsylvania, Johnson & Johnson, Inc.
    Inventors: Hansell Hall Stedman, Geoffrey Tabin, Charles R. Bridges